ライフサイエンスコーパス: Chlamydia

1 anicolaou smear, screening for gonorrhea and chlamydia).

2 assified as having spontaneous resolution of chlamydia.

3 t decrease the incidence of gonorrhea and/or chlamydia.

4 ble to home screening for BV, gonorrhea, and chlamydia.

5 SE and IC31(R) enhanced protection to TB and chlamydia.

6 utcome was the incidence of gonorrhea and/or chlamydia.

7 rves as a functional replacement for FtsZ in Chlamydia.

8 of CT009 showed uniform membrane staining in Chlamydia.

9 uld direct future technological advances for Chlamydia.

10 netic tools for demonstrating secretion from chlamydia.

11 75.0], respectively), but not with anorectal chlamydia.

12 at both visits, suggesting absence of recent chlamydia.

13 l molecular targets for therapeutics against Chlamydia.

14 igating the significance of gastrointestinal Chlamydia.

15 e of HIV (1.12 cases/100 person-years (PY)), chlamydia (9.47 cases/100 PY), active syphilis (4.01 cas

16 eria but is missing from Chlamydia Thus, how Chlamydia, a Trp auxotroph, responds to Trp starvation i

17 The obligate intracellular bacterium Chlamydia abortus is the causative agent of enzootic abo

18 1776 (89%) of 1936 NCSP patients without chlamydia accessed results online.

19 e estimate the association between diagnosed chlamydia and episodes of hospital health care (inpatien

20 tes with antibody to protect against genital chlamydia and establish neutrophils as a key effector ce

21 are the recommended screening guidelines for chlamydia and gonorrhea in men and women in the United S

22 Overall testing for chlamydia and gonorrhea increased from 22% to 42% (PTREN

23 ong men, 181/830 (21.8%) and 108/840 (12.9%) chlamydia and gonorrhea infections, respectively, were i

24 niversal anorectal screening with respect to chlamydia and gonorrhea prevalence and risk factors.

25 While the evidence for screening men for chlamydia and gonorrhea remains insufficient at this tim

26 portunity to monitor at-risk individuals for chlamydia and gonorrhea.

27 sk for infection should be screened for both chlamydia and gonorrhea.

28 ntify determinants associated with anorectal chlamydia and gonorrhea.

29 Chlamydia and Haemophilus infections increase NLRP3, cas

30 We developed mouse models of Chlamydia and Haemophilus respiratory infection-mediated

31 thin extrusions upon the interaction between Chlamydia and host dendritic cells.

32 or reverse and forward genetic approaches in Chlamydia and should serve as a valuable resource to the

33 d to manage anorectal Chlamydia trachomatis (chlamydia) and Neisseria gonorrhoeae (gonorrhea) infecti

34 xually transmitted genital tract infections (chlamydia), and invasive lymphogranuloma venereum (LGV)

35 cidences of gonorrhoea, 12 487 incidences of chlamydia, and 1002 incidences of co-infection.

36 V medical care who were tested for syphilis, chlamydia, and gonorrhea in the past 12 months by year a

37 We examined temporal trends in syphilis, chlamydia, and gonorrhea testing among sexually active H

38 lly active HIV-infected adults for syphilis, chlamydia, and gonorrhea.

39 ns be tested at least annually for syphilis, chlamydia, and gonorrhea.

40 ical dysplasia, herpes simplex virus type 2, chlamydia, and syphilis.

41 linic (eSHC), in which patients with genital chlamydia are diagnosed and medically managed via an aut

42 Species of Chlamydia are the etiologic agent of endemic blinding tr

43 Unfortunately, many microbes, including Chlamydia, are not amenable to routine molecular genetic

44 a suboptimal control strategy for anorectal chlamydia, as we found a high prevalence in women both w

45 lls and macrophages, and free, extracellular Chlamydia bacteria, such as those resulting from lysis.

46 infections, including rectal gonorrhoea and chlamydia, between groups, despite a suggestion of risk

47 exually-transmitted infections (STI) such as Chlamydia can be revolutionized by highly sensitive nucl

48 However, Chlamydia can experience amino acid starvation when the

49 variables were compared between rectal-only chlamydia cases and genitourinary cases using chi(2) or

50 In this study, we compared two variants of Chlamydia caviae, contrasting in virulence, with respect

51 After intravaginal infection with Chlamydia, CCR7-deficient mice displayed markedly reduce

52 A minority (15%) also had urethral chlamydia coinfection.

53 , we investigated the mechanism by which the Chlamydia-containing vacuole, termed the inclusion, esta

54 We discuss the challenges for chlamydia control and evidence to support a shift from t

55 fection hampers the design of evidence-based chlamydia control programmes.

56 ultiplex assay for simultaneous detection of chlamydia (CT), gonorrhea (GC), and trichomonas (TV).

57 trusion dramatically affected the outcome of Chlamydia-dendritic cell interactions for both the bacte

58 The vital role of UPR pathways in Chlamydia development and pathogenesis could lead to the

59 a infections are important for understanding chlamydia epidemiology and designing control interventio

60 lymphoma, human herpes virus (HHV)-6, HHV-7, chlamydia, Epstein-Barr virus (EBV) and bacterial 16S ri

61 s other than cervical cancer, gonorrhea, and chlamydia, for which the USPSTF has already made specifi

62 Participants were untreated patients with chlamydia from genitourinary medicine clinics, untreated

63 ry medicine clinics, untreated patients with chlamydia from six areas in England in the National Chla

64 y and new challenges in the nascent field of Chlamydia genetics.

65 Of all anorectal chlamydia/gonorrhea cases, 72% (n = 92)/33% (n = 4) were

66 Overall anorectal chlamydia/gonorrhea positivity was 13.4% (n = 127)/1.3%

67 ess of an e-STI testing and results service (chlamydia, gonorrhoea, HIV, and syphilis) on STI testing

68 able sexually transmitted infections (STIs): chlamydia, gonorrhoea, syphilis, and trichomoniasis.

69 , while uptake of an equivalent dose of free Chlamydia had no such effect.

70 Novel mouse models of Chlamydia, Haemophilus influenzae, influenza, and respir

71 Chlamydia has been detected in the gastrointestinal trac

72 evolving to an obligate intracellular niche, Chlamydia has streamlined its genome by eliminating supe

73 Chlamydia-host cell interaction therefore constitutes a

74 t vaccinated, and higher among those who had chlamydia, human immunodeficiency virus, or pregnancy te

75 in 28.9% (18.0-39.8) of participants, rectal chlamydia in 14.6% (5.4-23.8), and gonorrhoea in 13.5% (

76 valuate plasmid-independent pathogenicity of Chlamydia in susceptible mice.

77 CpoS-deficient Chlamydia induced an exacerbated type I interferon respo

78 d cell death, suggesting that STING mediates Chlamydia-induced cell death independent of its role in

79 hils stimulate ESC proliferation and prevent Chlamydia-induced endometrial damage.

80 genesis, we investigated the hypothesis that chlamydia-induced fibrosis is caused by EMT-driven gener

81 Although Chlamydia-induced hydrosalpinx in women and mice has bee

82 We hypothesized that Chlamydia induces UPR and exploits it to upregulate host

83 e presence of muramyl di- and tripeptides in Chlamydia-infected cell lysate fractions.

84 This is the first study of Chlamydia-infected cells showing the effect of an enviro

85 that CPAF can tolerate more mutations inside Chlamydia-infected cells than in cell-free systems.

86 We used data from published studies of chlamydia-infected men who were retested at a later date

87 mmunity for restricting UGT tissue damage in Chlamydia-infected mice, and in initial studies intravag

88 and tissue repair are elicited in the UGT of Chlamydia-infected women.

89 doxycycline for the treatment of urogenital chlamydia infection among adolescents in youth correctio

90 ncy, and tubal factor infertility) following chlamydia infection and repeat infection hampers the des

91 A single diagnosed chlamydia infection increased the risk of all complicati

92 volved in humoral protection against genital chlamydia infection is crucial to development of an effe

93 that the robust type 2 immunity elicited by Chlamydia infection of human genital tissue may analogou

94 metrial leukocyte (constitutively and during Chlamydia infection), whereas studies with eosinophil-de

95 did not affect T cell-mediated clearance of Chlamydia infection, consistent with a B cell-specific r

96 Chlamydia infection, therefore, constitutes a significan

97 uently suffer from ocular diseases caused by Chlamydia infection, we also examined the eye microbiome

98 . trachomatis organism load in human genital chlamydia infection.

99 gulated over the course of the intracellular Chlamydia infection.

100 roduction, revealing that retromer restricts Chlamydia infection.

101 l as essential for endometrial repair during Chlamydia infection.

102 tor-6alpha (ATF6alpha)-were activated during Chlamydia infection.

103 s estimates for clearance rates of untreated chlamydia infections are important for understanding chl

104 both groups, treated baseline gonorrhoea and chlamydia infections, and assessed 9-month gonorrhoea an

105 on and thereby shape macrophage responses to Chlamydia infections.

106 tent stem cells (iPSdMs) to study macrophage-Chlamydia interactions in vitro.

107 Chlamydia is a medically important bacterium that infect

108 Chlamydia is a prevalent sexually transmitted disease th

109 Chlamydia is an obligate intracellular bacterium that re

110 ment of approaches to genetically manipulate Chlamydia is fostering important advances in understandi

111 Chlamydia is responsible for millions of new infections

112 A Chlamydia-like endosymbiont has previously enhanced Acan

113 Additionally, Chlamydia maintain mitochondrial integrity during reacti

114 assified as having spontaneous resolution of chlamydia might have been exposed to C. trachomatis but

115 MOMP protein from the mouse-specific species Chlamydia muridarum (MoPn-MOMP or mMOMP).

116 munity of hysterectomized mice infected with Chlamydia muridarum and Chlamydia trachomatis to determi

117 h CD4 T cells that respond to a common Ag in Chlamydia muridarum and Chlamydia trachomatis Using an a

118 tended this analysis to DHFR originated from Chlamydia muridarum and Listeria grayi We found that the

119 The cryptic plasmid is essential for Chlamydia muridarum dissemination from the genital tract

120 Using the Chlamydia muridarum genital infection model of mice, whi

121 Although modern Chlamydia muridarum has been passaged for decades, there

122 Intravaginal infection with Chlamydia muridarum in mice can ascend to the upper geni

123 with plasmid-competent but not plasmid-free Chlamydia muridarum induces hydrosalpinx in mouse upper

124 le clearance of primary or secondary genital Chlamydia muridarum infection but significantly reduced

125 dilation detected microscopically following Chlamydia muridarum infection.

126 Using the Chlamydia muridarum model of genital infection, we demon

127 anuloma venereum (LGV) and the murine strain Chlamydia muridarum share 99% of their gene content.

128 We have recently shown that Chlamydia muridarum spreads from the genital tract to th

129 We have previously shown that wild-type Chlamydia muridarum spreads to and establishes stable co

130 eficient mice would affect host responses to Chlamydia muridarum within the reproductive tract.

131 in the genital tracts of mice infected with Chlamydia muridarum, a model for investigating the human

132 Chlamydia muridarum, a model pathogen for investigating

133 the tc0668 gene of serial in vitro-passaged Chlamydia muridarum, a murine model of human urogenital

134 nfected C57BL/6 mice with two populations of Chlamydia muridarum, each comprised of multiple genetic

135 show that PVs formed by the rodent pathogen Chlamydia muridarum, so-called inclusions, remain free o

136 We screened a library of Chlamydia mutants for modulators of cell death.

137 ram-negative bacilli, Staphylococcus aureus, Chlamydia, Mycoplasma, and Legionella are each identifie

138 of specialized bacteria, such as pathogenic Chlamydia or aquatic Planctomycetes, that lack FtsZ but

139 eive MeNZB, and diagnosed with gonorrhoea or chlamydia, or both.

140 ecimen type and site of sampling, and viable chlamydia organism load may be a more important indicato

141 Chlamydia organism load varies by specimen type and site

142 3 and 22 LHJs provided data on gonorrhea and chlamydia outcomes, respectively.

143 these characteristics to be discovered for a Chlamydia pathogen.

144 For almost 2 decades, results from Chlamydia pathogenesis investigations have been conceptu

145 and note a comfortable concordance with the Chlamydia pathogenesis literature.

146 act, highlighting the importance of CpoS for Chlamydia pathogenesis.

147 s with chlamydia who consented to the online chlamydia pathway who then received appropriate clinical

148 ApoB100, HSP60 and outer membrane protein of chlamydia pneumonia) in stabilizing advanced atheroscler

149 ly of polymorphic membrane proteins (Pmp) in Chlamydia pneumoniae consists of 21 members.

150 Chlamydia pneumoniae infection is implicated in atherosc

151 Chlamydia pneumoniae is an important human pathogen, but

152 ection after having been contact-traced by a chlamydia-positive partner were more likely to have CVM

153 with an approximately 10% reduction in both chlamydia positivity and gonorrhea incidence, though the

154 e bounds on these outcomes both crossed one (chlamydia positivity prevalence ratio = 0.89, 95% CI 0.7

155 tion of the inclusion membrane protein CpoS (Chlamydia promoter of survival) induced rapid apoptotic

156 We show that the Chlamydia protein IncV, which is inserted into the inclu

157 The prevalence of rectal chlamydia ranged from 11.7% to 13.5%.

158 ections, and assessed 9-month gonorrhoea and chlamydia reinfection as the primary outcome.

159 icantly lower odds of combined gonorrhoea or chlamydia reinfection than did control patients (58/508

160 the central role of antibody in immunity to chlamydia reinfection, and demonstrate a key function fo

161 therapeutic intervention strategy to prevent chlamydia-related complications.

162 Chlamydia remains the most commonly diagnosed bacterial

163 were IgG1+IgG3+, consistent with more recent chlamydia resolution.

164 tin/ubiquitin-like cross-reactive enzymes in Chlamydia, Rickettsia, and Xanthomonas.

165 enrichment in host processes consistent with Chlamydia's intracellular life cycle.

166 is study provides an improved description of chlamydia's natural history to inform public health deci

167 eline cervical cytology result, and baseline Chlamydia screening (as proxy for sexual experience).

168 ed Finnish male adolescents participating in chlamydia screening 4 years after vaccination with AS04-

169 ia from six areas in England in the National Chlamydia Screening Programme's (NCSP) online postal tes

170 Kingdom before introduction of the National Chlamydia Screening Programme.

171 distinct, host-membrane-bound compartment of Chlamydia separate from the original infected cell.

172 chlamydial protease-like activity factor), a Chlamydia serine protease, is activated via proximity-in

173 red invasion displayed by the tmeA strain of Chlamydia, since AHNAK-deficient cells revealed no invas

174 status of the molecular genetic toolbox for Chlamydia species and highlights new insights into their

175 Most Chlamydia species carry a 7.5kb plasmid encoding eight o

176 stability, we tested the ability of various Chlamydia species to alter direct MHC class I antigen pr

177 y to perform a molecular genetic analysis of Chlamydia species.

178 In addition, Chlamydia-specific Ab responses were dysregulated in CCR

179 the immunoglobulin class or magnitude of the Chlamydia-specific antibody response or to recruitment o

180 The Chlamydia-specific CD4 T cell response is characterized

181 Adoptive transfer of Chlamydia-specific CD4 TCR-Tg T cells with polyfunctiona

182 necrosis factor alpha (TNF-alpha)-producing Chlamydia-specific CD8(+) T cells cause oviduct patholog

183 es key factors shaping memory development of Chlamydia-specific CD8(+) T cells that will inform futur

184 n, we demonstrate a protective role for both Chlamydia-specific immunoglobulin G (IgG) and polymorpho

185 thology, but unlike women, does not generate Chlamydia-specific TH2 immunity.

186 c health threat, underscoring the need for a Chlamydia-specific vaccine.

187 pitope mapping of immunodominant proteins of Chlamydia spp.

188 ide from live-animal markets and examined by Chlamydia spp. 23 S rRNA gene FRET-PCR followed by high-

189 % of the birds (602/2,300) were positive for Chlamydia spp. and five Chlamydia spp. were identified.

190 Chlamydia spp. are obligate intracellular bacteria and,

191 Pathogenically diverse Chlamydia spp. can have surprisingly similar genomes.

192 investigate the prevalence and diversity of Chlamydia spp. in domestic birds in China, oral and cloa

193 A region of high genomic diversity between Chlamydia spp. termed the plasticity zone (PZ) may encod

194 0) were positive for Chlamydia spp. and five Chlamydia spp. were identified.

195 Chlamydia strains express a major outer-membrane protein

196 We used a subset of the national Danish Chlamydia Study.

197 stration System) who did not have a positive chlamydia test during this interval.

198 nd controls were individuals with a positive chlamydia test only.

199 The main study outcomes were chlamydia test positivity among women ages 14-25 y in 21

200 ark (including Greenland) who had a positive chlamydia test recorded by a public health microbiology

201 A positive syphilis, gonorrhea, or chlamydia test was significantly associated with class m

202 postal testing service, or patients without chlamydia tested in the same six NCSP areas.

203 imens from females aged <25 years undergoing chlamydia testing were collected, together with demograp

204 rvation in most bacteria but is missing from Chlamydia Thus, how Chlamydia, a Trp auxotroph, responds

205 Evading cell death is critical for Chlamydia to maintain a replicative niche, but the under

206 ntigens from M. tuberculosis, influenza, and chlamydia to test immune-profiles and efficacy in infect

207 mation of the membrane of the human pathogen Chlamydia trachomatis (C.t.).

208 sex or symptoms is used to manage anorectal Chlamydia trachomatis (chlamydia) and Neisseria gonorrho

209 Chlamydia trachomatis (Ct) has been associated with misc

210 The obligate-intracellular pathogen Chlamydia trachomatis (Ct) has undergone considerable ge

211 he diagnosis and management of uncomplicated Chlamydia trachomatis (CT) infection in adolescents and

212 Genital Chlamydia trachomatis (Ct) infection induces protective

213 The frequency and duration of Chlamydia trachomatis (Ct) ocular infections decrease wi

214 odel of HIV, Neisseria gonorrhoeae (NG), and Chlamydia trachomatis (CT) transmission dynamics among M

215 mSIBA) that allows simultaneous detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG),

216 An example is infection with Chlamydia trachomatis (Ct), which is the most common sex

217 We tested 30 potentially Chlamydia trachomatis (CT)-infected patients in a hospit

218 Trachoma is caused by Chlamydia trachomatis (Ct).

219 tercourse for Neisseria gonorrhoeae (GC) and Chlamydia trachomatis (CT).

220 acid amplification tests (NAATs) that detect Chlamydia trachomatis AC2 also detects Neisseria gonorrh

221 ind that C. muridarum and the human pathogen Chlamydia trachomatis activate not only NLRP3 but also A

222 iable analysis were vaccine status, positive Chlamydia trachomatis and >/=4 partners in the preceding

223 Chlamydia trachomatis and Mycoplasma genitalium coinfect

224 se of infertility and ectopic pregnancy, and Chlamydia trachomatis and Neisseria gonorrhoeae are reco

225 ing (NAAT) is the preferred method to detect Chlamydia trachomatis and Neisseria gonorrhoeae, but no

226 isease associations, which parallel those of Chlamydia trachomatis and Neisseria gonorrhoeae, the mec

227 of the two most common bacterial infections: Chlamydia trachomatis and Neisseria gonorrhoeae.

228 tigated whether coinfection of macaques with Chlamydia trachomatis and Trichomonas vaginalis decrease

229 Although most individuals infected with Chlamydia trachomatis are initially asymptomatic, sympto

230 We recently detected PG in Chlamydia trachomatis by a new metabolic cell wall label

231 Chlamydia trachomatis can enter a viable but nonculturab

232 Ocular infection with Chlamydia trachomatis can lead to trachoma, a leading in

233 Chlamydia trachomatis causes both trachoma and sexually

234 Chlamydia trachomatis causes sexually transmitted infect

235 Chlamydia trachomatis conjunctivitis may present with ex

236 Obligate intracellular bacteria such as Chlamydia trachomatis depend on metabolites of the host

237 Chlamydia trachomatis elementary body enzyme-linked immu

238 erinary relatives, the oculogenital pathogen Chlamydia trachomatis evolved as a commensal organism of

239 Chlamydia trachomatis exits host epithelial cells throug

240 Chlamydia trachomatis genital tract infection is a major

241 The human pathogen Chlamydia trachomatis grows in a glycogen-rich vacuole.

242 .09, 0.66), and Neisseria gonorrhoeae and/or Chlamydia trachomatis had 92% lower odds of any adverse

243 We show that a LipL2 enzyme from Chlamydia trachomatis has similar activity, demonstratin

244 hock proteins of the intracellular bacterium Chlamydia trachomatis have been associated with immune p

245 atural infection induces partial immunity to Chlamydia trachomatis Identification of chlamydial antig

246 Women who tested positive for Chlamydia trachomatis infection after having been contac

247 ral discharge to diagnose N. gonorrhoeae and Chlamydia trachomatis infection in certain populations b

248 Urogenital Chlamydia trachomatis infection remains prevalent and ca

249 w-up studies in a murine model of intranasal Chlamydia trachomatis infection, we analogously found th

250 ation of women notified by a sex partner for Chlamydia trachomatis infection.

251 ociated with pathological sequelae of ocular Chlamydia trachomatis infections in The Gambia.

252 Genital Chlamydia trachomatis infections in women typically are

253 The bacterial pathogen Chlamydia trachomatis is a global health burden currentl

254 Chlamydia trachomatis is a global health burden due to i

255 Chlamydia trachomatis is a leading cause of genital and

256 Chlamydia trachomatis is an important human pathogen tha

257 Chlamydia trachomatis is an important risk factor for PI

258 Chlamydia trachomatis is an obligate intracellular epith

259 Chlamydia trachomatis is an obligate intracellular human

260 Chlamydia trachomatis is an obligate intracellular patho

261 Chlamydia trachomatis is an obligate intracellular patho

262 current or long-term infections of humans by Chlamydia trachomatis is poorly understood.

263 Chlamydia trachomatis is the leading cause of infection-

264 The obligate intracellular bacterium Chlamydia trachomatis is the most common cause of bacter

265 Chlamydia trachomatis is the most common notifiable dise

266 Chlamydia trachomatis is the world's most prevalent bact

267 Chlamydia trachomatis isolates that cause trachoma, sexu

268 The VD4 region from the Chlamydia trachomatis major outer membrane protein conta

269 ed on filter paper to test for antibodies to Chlamydia trachomatis pgp3 using a multiplex bead assay.

270 Comparator assays included BD ProbeTec Chlamydia trachomatis Q(x) (CTQ)/Neisseria gonorrhoeae Q

271 Chlamydia trachomatis remains a leading cause of bacteri

272 Obligate intracellular Chlamydia trachomatis replicate in a membrane-bound vacu

273 We now report that a Chlamydia trachomatis strain deficient in expression of

274 d mice infected with Chlamydia muridarum and Chlamydia trachomatis to determine if there were differe

275 ted, we purified and analyzed three putative Chlamydia trachomatis topoisomerases.

276 nd to a common Ag in Chlamydia muridarum and Chlamydia trachomatis Using an adoptive-transfer approac

277 urine samples) for Neisseria gonorrhoeae and Chlamydia trachomatis using nucleic acid amplification t

278 nto the eukaryotic host cell is required for Chlamydia trachomatis virulence.

279 n a community with a high prevalence of STI, Chlamydia trachomatis was detected in 8.7% and Neisseria

280 ndida albicans, Streptococcus agalactiae and Chlamydia trachomatis with a single biochip, enabling a

281 In the class I-c beta subunit from Chlamydia trachomatis, a heterodinuclear Mn(II)/Fe(II) c

282 Chlamydia trachomatis, a leading bacterial cause of sexu

283 lesion, and changes in sexual behaviors and Chlamydia trachomatis, an infection with similar epidemi

284 bacter baumannii, Burkholderia pseudomallei, Chlamydia trachomatis, Escherichia coli, Klebsiella pneu

285 assessed the intervention effect on incident Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycopl

286 a, and first-void female urine specimens for Chlamydia trachomatis, Neisseria gonorrhoeae, and Tricho

287 sites were tested for M. genitalium and for Chlamydia trachomatis, Neisseria gonorrhoeae, and Tricho

288 e new insights concerning the concurrence of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma

289 uently drink alcohol and to be infected with Chlamydia trachomatis, Neisseria gonorrhoeae, or herpes

290 or infertility (TFI) that is attributable to Chlamydia trachomatis, the population excess fraction (P

291 xual transmission is probably lower than for Chlamydia trachomatis.

292 a model for investigating the human pathogen Chlamydia trachomatis.

293 As Chlamydia vaccines enter the preclinical pipeline and, i

294 The incidence of gonorrhea and/or chlamydia was 19.1 per 100 person-years (95% confidence

295 Whereas Chlamydia was comparably cleared in all groups, IL-4(-/-

296 ition except cervical cancer, gonorrhea, and chlamydia, which are covered by other USPSTF screening r

297 rapid and enhanced immune activation against Chlamydia, which results in rapid microbial clearance, w

298 d an aerobic heterotrophic lifestyle for the chlamydia, which were found intracellularly in Onychodro

299 outcome was the proportion of patients with chlamydia who consented to the online chlamydia pathway

300 and feasible for management of patients with chlamydia, with preliminary evidence of similar treatmen